IDH.L Share News (IDH)
IDH Share
IDH Share
IDH Share
IDH Share
IDH
IDH Share
IDH Broker
IDH Directors
IDH Financial
IDH
IDH Short
IDHMon, 11th Jul 2016 12:14
LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC on Monday said Non-Executive Director Peter Kaspar bought 4,100 shares at a price of EUR1.657 each last Friday and Thursday.
Following this transaction, Kaspar is interested in 15,100 shares, or a 0.05% stake.
Shares in the medical diagnostic test kits provider were up 2.5% at 142.00 pence Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%
Read moreIN BRIEF: Immunodiagnostic Systems Launches Covid Assay Test For Sale
Read more
(Sharecast News) - Immunodiagnostic Systems announced on Friday that its fully-automated SARS-CoV-2 IgM antibody test for Covid-19 was now available for sale.
Read moreUK TRADING UPDATE SUMMARY: Games Workshop Notes AGM Revolt Over Chair
Read more(Sharecast News) - Laboratory diagnostics specialist Immunodiagnostic Systems announced the launch of four new 'i-Tracker' assays designed to run on its automated 'IDS-iSYS' analyser on Wednesday.
Read moreUK TRADING UPDATE SUMMARY: BATM Gets First Tier One NFVTime Customer
Read moreUK TRADING UPDATE SUMMARY: Topps Tiles Sales Up As Lockdowns Ease
Read moreIN BRIEF: Immunodiagnostic Systems Launches Automated Cortisol Test
Read moreUK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump
Read moreIN BRIEF: Immunodiagnostic Launches Virus Antibody Test
Read more(Sharecast News) - Laboratory diagnostic services provider Immunodiagnostic Systems announced on Tuesday that its "fully automated" SARS-CoV-2 (Covid-19) IgG antibody test was available for sale.
Read more(Sharecast News) - In-vitro diagnostics provider Immunodiagnostic Systems met its target of maintaining like-for-like revenue in its final results on Wednesday, with group revenue rising by 2% on a like-for-like basis to £39.3m, making for its second consecutive year of revenue growth.
Read moreImmunodiagnostic Annual Profit Soars But Warns Of Hit From Less Work
Read moreImmunodiagnostic Shares Soar As Covid Testing Product Gets CE Marking
Read moreUK WINNERS & LOSERS SUMMARY: Immunodiagnostic Virus Test Now For Sale
Read more